Loading…
GRAVOL IMMEDIATE RELEASE & LONG ACTING is a brand name for Dimenhydrinate, supplied as a tablet (combined release). The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: AND CLINICAL USE ................................................................................................... 4 CONTRAINDICATIONS ......................................................................................................................... 4 WARNINGS AND PRECAUTIONS…
Verbatim from this product's HC label. Tap a section to expand.
Drowsiness and dizziness are reported most frequently, particularly on high dosage. Pain may occur at the site of IM injection. Since dimenhydrinate contains 50% diphenhydramine, the possibility of diphenhydramine side effects must also be considered.
The following adverse reactions have also been reported:
Blood and lymphatic system disorders: anemia, thrombocytopenia, agranulocytosis, leukopenia, pancytopenia. Body as a whole - general disorders: lassitude, fatigue, drug withdrawal syndrome, injection site inflammation. Cardiac disorders: tachycardia, palpitations, hypotension, arrhythmia.
Ear and labyrinth disorders: tinnitus, labyrinthitis, vertigo. Eye disorders: mydriasis, vision blurred, diplopia. Gastrointestinal disorders: epigastric distress, nausea, dry mouth, constipation, diarrhea, vomiting General disorders and administration site conditions: oedema.
Immune system disorders: hypersensitivity, anaphylactic reaction. Metabolism and nutrition disorders: anorexia, decreased appetite. Nervous system disorders: dizziness, headache, impaired coordination, somnolence, tremor, paraesthesia, ataxia, athetosis, convulsion, seizure, memory impairment, loss of consciousness.
Psychiatric disorders: depression, insomnia, hallucination, anxiety, confusional state, excitation, euphoric mood, nightmares, delirium, irritability, nervousness, restlessness, agitation. Respiratory, thoracic, and mediastinal disorders: thickening of bronchial secretions, respiratory depression, dyspnoea.
Renal and urinary disorders: dysuria, urinary retention. Skin and subcutaneous tissue disorders: angioedema, hyperhidrosis, rash, rash erythematous, rash maculopapular, pruritus, urticaria, fixed drug eruption, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiform, photosensitivity.
Vascular disorders: hypotension, hypertension, flushing. GRAVOL® Product Monograph Page 8 of
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Dimenhydrinate in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.